Vaccine. 2002 Jun 7;20(19-20):2623-34.

Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol.

Waag DM, England MJ, Tammariello RF, Byrne WR, Gibbs P, Banfield CM, Pitt ML.

Source

Pathogenesis and Immunology Branch, Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702-5011, USA. david.waag@det.amedd.army.mil

Abstract

Preliminary evidence gathered in rodents and livestock suggested that a phase I chloroform:methanol residue (CMR) extracted vaccine was safe and efficacious in protecting these animals from challenge with the obligate phagolysosomal pathogen (Coxiella burnetii). Prior to the initiation of phase II studies in human volunteers, we compared, in non-human primates (Macaca fascicularis), the efficacy of CMR vaccine with Q-Vax, a licensed cellular Australian Q fever vaccine that has been demonstrated to provide complete protection in human volunteers. Vaccine efficacy was assessed by evaluating thoracic radiographs and the presence of fever and bacteremia in monkeys challenged by aerosol with Coxiella burnetii. Changes in blood chemistries, hematology, behavior and pulmonary function were also examined. CMR, whether administered in single 30 or 100 microg doses or two 30 microg subcutaneous doses, gave equivalent protection in vaccine recipients as a single 30 microg dose of Q-Vax. In addition, vaccination resulted in significant, although temporary, increases in specific antibody titers against C. burnetii phases I and II antigens. The C. burnetii CMR vaccine may be an efficacious alternative to cellular Q fever vaccines in humans.

PMID:: 12057622; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol. [Vaccine. 1997]
Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol.
Waag DM, England MJ, Pitt ML. Vaccine. 1997 Nov; 15(16):1779-83.
Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever. [Infect Immun. 1993]
Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever.
Fries LF, Waag DM, Williams JC. Infect Immun. 1993 Apr; 61(4):1251-8.
Review Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals. [Ann N Y Acad Sci. 1992]
Review Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals.
Williams JC, Peacock MG, Waag DM, Kent G, England MJ, Nelson G, Stephenson EH. Ann N Y Acad Sci. 1992 Jun 16; 653:88-111.
Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines. [Comp Med. 2000]
Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines.
Wilhelmsen CL, Waag DM. Comp Med. 2000 Aug; 50(4):374-8.
Review Vaccines against Coxiella infection. [Expert Rev Vaccines. 2004]
Review Vaccines against Coxiella infection.
Zhang G, Samuel JE. Expert Rev Vaccines. 2004 Oct; 3(5):577-84.

See reviews... See all...

Cited by 4 PubMed Central articles

Efficient activation of T cells by human monocyte-derived dendritic cells (HMDCs) pulsed with Coxiella burnetii outer membrane protein Com1 but not by HspB-pulsed HMDCs. [BMC Immunol. 2011]
Efficient activation of T cells by human monocyte-derived dendritic cells (HMDCs) pulsed with Coxiella burnetii outer membrane protein Com1 but not by HspB-pulsed HMDCs.
Wang Y, Xiong X, Wu D, Wang X, Wen B. BMC Immunol. 2011 Sep 3; 12:52. Epub 2011 Sep 3.
Immunoreactive Coxiella burnetii Nine Mile proteins separated by 2D electrophoresis and identified by tandem mass spectrometry. [Microbiology. 2011]
Immunoreactive Coxiella burnetii Nine Mile proteins separated by 2D electrophoresis and identified by tandem mass spectrometry.
Deringer JR, Chen C, Samuel JE, Brown WC. Microbiology. 2011 Feb; 157(Pt 2):526-42. Epub 2010 Oct 28.
Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection. [Infect Immun. 2007]
Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection.
Ochoa-Repáraz J, Sentissi J, Trunkle T, Riccardi C, Pascual DW. Infect Immun. 2007 Dec; 75(12):5845-58. Epub 2007 Sep 24.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (...
Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol.
Vaccine. 2002 Jun 7 ;20(19-20):2623-34.

PubMed
Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? ...
Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial.
Lancet. 2002 Jun 1 ;359(9321):1877-90.

PubMed
[Quality of manuscript evaluation in Gaceta Sanitaria].
[Quality of manuscript evaluation in Gaceta Sanitaria].
Gac Sanit. 2002 May-Jun ;16(3):244-9.

PubMed
Can altered production of interleukin-1beta, interleukin-6, transforming growth ...
Can altered production of interleukin-1beta, interleukin-6, transforming growth factor-beta and prostaglandin E(2) by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients.
Osteoarthritis Cartilage. 2002 Jun ;10(6):491-500.

PubMed
Human cardiac valve interstitial cells in collagen sponge: a biological three-di...
Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering.
J Heart Valve Dis. 2002 May ;11(3):298-306; discussion 306-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 4 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information